United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 2 | 4 |
| 2017 | 25 | 70 | 95 |
| 2018 | 21 | 60 | 81 |
| 2019 | 10 | 31 | 41 |
| 2020 | 6 | 46 | 52 |
| 2021 | 5 | 24 | 29 |
To return to the timeline, click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Understanding Drug Development: A Primer on the Food and Drug Administration. J Pediatric Infect Dis Soc. 2021 Nov 11; 10(10):977-981.
-
FDA's commitment to transparency. Am J Health Syst Pharm. 2021 08 30; 78(17):1550-1551.
-
Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976-2020): Portends Intrinsic Industrial Transformation and Independence of Certain Crises. Ther Innov Regul Sci. 2022 01; 56(1):104-116.
-
Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations. J Am Acad Dermatol. 2021 Nov; 85(5):1113-1116.
-
Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19. Med Sci Monit. 2021 Aug 16; 27:e934393.
-
Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data. Expert Opin Drug Saf. 2021 Dec; 20(12):1559-1564.
-
EUAdb: A resource for COVID-19 test development and comparison. PLoS One. 2021; 16(8):e0255417.
-
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Neuro Oncol. 2021 08 02; 23(8):1252-1260.
-
Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of Abuse. J Clin Pharmacol. 2021 08; 61 Suppl 2:S129-S141.
-
?US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access. Health Aff (Millwood). 2021 08; 40(8):1243-1251.